Deficiency of brain ATP-binding cassette transporter A-1 exacerbates blood-brain barrier and white matter damage after stroke

Stroke

Volumn 46, Issue 3, 2015, Pages 827-834

  Cui, Xu ^a   Chopp, Michael ^a,b   Zacharek, Alex ^a   Karasinska, Joanna M ^d   Cui, Yisheng ^a   Ning, Ruizhuo ^a   Zhang, Yi ^a   Wang, Yun ^c   Chen, Jieli ^a  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aquaporin 4; ATP binding cassette transporter A 1; Blood brain barrier; Insulin like growth factor binding protein 1; Stroke; White matter

Indexed keywords

ABC TRANSPORTER A1; ALBUMIN; AQUAPORIN 4; GELATINASE B; MESSENGER RNA; PROTEIN; SOMATOMEDIN C; ABCA1 PROTEIN, MOUSE; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; MMP9 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE CULTURE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WHITE MATTER INJURY; ANIMAL; ASTROCYTE; BLOOD; BRAIN INJURY; CELL CULTURE; CEREBRAL ARTERY DISEASE; CYTOLOGY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TREATMENT OUTCOME; WHITE MATTER;

ANIMALS; ASTROCYTES; ATP BINDING CASSETTE TRANSPORTER 1; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; INSULIN-LIKE GROWTH FACTOR I; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; STROKE; TREATMENT OUTCOME; WHITE MATTER;

EID: 84939225420     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007145     Document Type: Article

References (35)

1. Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, et al. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem. 2004;279:41197-41207. doi: 10.1074/jbc. M407962200.
2. Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, et al. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem. 2004;279:40987-40993. doi: 10.1074/jbc. M407963200.
3. Karasinska JM, Rinninger F, Lütjohann D, Ruddle P, Franciosi S, Kruit JK, et al. Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J Neurosci. 2009;29:3579-3589. doi: 10.1523/JNEUROSCI.4741-08.2009.
4. Cheng O, Ostrowski RP, Liu W, Zhang JH. Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB. Neuroscience. 2010;166:1101-1109. doi: 10.1016/j. neuroscience.2010.01.024.
5. Karasinska JM, de Haan W, Franciosi S, Ruddle P, Fan J, Kruit JK, et al. ABCA1 influences neuroinflammation and neuronal death. Neurobiol Dis. 2013;54:445-455. doi: 10.1016/j.nbd.2013.01.018.
6. Chen J, Zacharek A, Cui X, Shehadah A, Jiang H, Roberts C, et al. Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J Cereb Blood Flow Metab. 2010;30:102-109. doi: 10.1038/jcbfm.2009.187.
7. Cui X, Chopp M, Zacharek A, Cui Y, Roberts C, Chen J. The neurorestorative benefit of GW3965 treatment of stroke in mice. Stroke. 2013;44:153-161. doi: 10.1161/STROKEAHA.112.677682.
8. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem. 2009;284:32336-32343. doi: 10.1074/jbc. M109.047472.
9. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12:723-738. doi: 10.1038/nrn3114.
10. Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci. 2011;14:1398-1405. doi: 10.1038/nn. 2946.
11. Kim WS, Guillemin GJ, Glaros EN, Lim CK, Garner B. Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. Neuroreport. 2006;17:891-896. doi: 10.1097/01.wnr.0000221833.41340.cd.
12. Lin S, Fan LW, Pang Y, Rhodes PG, Mitchell HJ, Cai Z. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 2005;1063:15-26. doi: 10.1016/j.brainres.2005.09.042.
13. Bake S, Selvamani A, Cherry J, Sohrabji F. Blood-brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One. 2014;9:e91427. doi: 10.1371/journal.pone.0091427.
14. Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC, Lv YC, et al. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway. Atherosclerosis. 2012;222:344-354. doi: 10.1016/j.atherosclerosis.2012.03.005.
15. Wallin A, Sjögren M, Edman A, Blennow K, Regland B. Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia. Eur Neurol. 2000;44:229-235.
16. Wu Y, Wang YP, Guo P, Ye XH, Wang J, Yuan SY, et al. A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury. J Mol Neurosci. 2012;46:483-491. doi: 10.1007/s12031-011-9620-5.
17. Freret T, Bouet V, Leconte C, Roussel S, Chazalviel L, Divoux D, et al. Behavioral deficits after distal focal cerebral ischemia in mice: usefulness of adhesive removal test. Behav Neurosci. 2009;123:224-230. doi: 10.1037/a0014157.
18. Nicchia GP, Nico B, Camassa LM, Mola MG, Loh N, Dermietzel R, et al. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience. 2004;129:935-945. doi: 10.1016/j.neuroscience.2004.07.055.
19. Zhang RL, Chopp M, Roberts C, Wei M, Wang X, Liu X, et al. Sildenafil enhances neurogenesis and oligodendrogenesis in ischemic brain of middleaged mouse. PLoS One. 2012;7:e48141. doi: 10.1371/journal.pone.0048141.
20. Chen J, Cui X, Zacharek A, Cui Y, Roberts C, Chopp M. White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke. 2011;42:445-452. doi: 10.1161/STROKEAHA.110.596486.
21. Crocker SJ, Frausto RF, Whitton JL, Milner R. A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Glia. 2008;56:1187-1198. doi: 10.1002/glia.20689.
22. Zhang R, Chopp M, Zhang ZG. Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci. 2013;7:201. doi: 10.3389/fncel.2013.00201.
23. Badaut J, Lasbennes F, Magistretti PJ, Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab. 2002;22:367-378. doi: 10.1097/00004647-200204000-00001.
24. He L, Zhang X, Wei X, Li Y. Progesterone attenuates aquaporin-4 expression in an astrocyte model of ischemia/reperfusion. Neurochem Res. 2014;39:2251-2261. doi: 10.1007/s11064-014-1427-7.
25. Fukuda AM, Badaut J. Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation. 2012;9:279. doi: 10.1186/1742-2094-9-279.
26. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010;68:409-427. doi: 10.1016/j.neuron. 2010.09.043.
27. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485:512-516. doi: 10.1038/nature11087.
28. Dore-Duffy P, Katychev A, Wang X, Van Buren E. CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab. 2006;26:613-624. doi: 10.1038/sj.jcbfm.9600272.
29. Jalal FY, Yang Y, Thompson J, Lopez AC, Rosenberg GA. Myelin loss associated with neuroinflammation in hypertensive rats. Stroke. 2012;43:1115-1122. doi: 10.1161/STROKEAHA.111.643080.
30. Yin KJ, Deng Z, Hamblin M, Zhang J, Chen YE. Vascular PPARδ protects against stroke-induced brain injury. Arterioscler Thromb Vasc Biol. 2011;31:574-581. doi: 10.1161/ATVBAHA.110.221267.
31. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001;21:7724-7732.
32. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med. 2006;12:441-445. doi: 10.1038/nm1387.
33. Russo VC, Gluckman PD, Feldman EL, Werther GA. Insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev. 2005;26:916-943. doi: 10.1210/er.2004-0024.
34. Madathil SK, Carlson SW, Brelsfoard JM, Ye P, D'Ercole AJ, Saatman KE. Astrocyte-specific overexpression of insulin-like growth factor-1 protects hippocampal neurons and reduces behavioral deficits following traumatic brain injury in mice. PLoS One. 2013;8:e67204. doi: 10.1371/journal.pone.0067204.
35. Guan J, Bennet L, Gluckman PD, Gunn AJ. Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol. 2003;70:443-462.